Introducing the BOSScsc®
Crossing Support Catheter
Our mission is to develop catheter based solutions that directly address clinical challenges in interventional CLI/CLTI limb salvage revascularizations. We believe purpose built technology leads to more successful procedures and better outcomes for patients.
We are a privately held catheter technology company that connects the clinician to world class catheter engineering. Our approach delivers devices to address unmet challenges and often leads to simple solutions for complex problems.
The Iatri Devices team is a diverse group of medical device and clinician innovators bringing together over 150 years of experience in advanced interventional catheter based technologies and limb salvage revascularization procedures.
Technology Advancements for Complex Disease
BOSScsc® Crossing Support Catheter
We started with a clear mission: to bring engineers and multi specialty clinicians together to create a crossing support catheter system that was specifically built to better manage complex, heavily calcified peripheral lesions. Our clinical partners needed a device that carries the durability to complete the procedure without failure, provide the ultimate in guidewire support, and have the trackability & pushability to successfully traverse all of the challenges present in peripheral revascularizations. We set out to design a simple, cost effective device to address a complex problem.
Experiencing catheter buckling and fatigue failures are frustrating, add time, and cost to procedures. These are common failures that are avoided with our monolithic coaxial design built into the BOSScsc®. Our MonoTech™ technology delivers unmatched catheter body and tip strength by incorporating one of the most advanced medical device polymers available.
Having a support catheter that can handle torque, extreme pushability, and deliver a reliable tip response is critical. The BOSScsc® with its MonoTech™ technology is built to withstand high torque clinical situations with unmatched pushability and tactile feel. This torque and pushability is especially effective when crossing long, highly calcified lesions and CTO's. By simply rotating our BOSScsc® catheters they propel forward, advancing through the most challenging crossing situations.
The BOSScsc® is a non-tapered coaxial design allowing the .018" catheters to operate within the .035" catheters, delivering telescoping performance in clinical situations requiring maximum support. The catheter hubs of the BOSScsc® are designed to be rotated and they couple together when telescoping, allowing the two individual catheters to operate as a single catheter system.
The challenge was to design a durable catheter body with the leverage of a rigid catheter, yet the flexibility to manage extreme tortuosity experienced in below the ankle (BTA) clinical procedures. To meet this challenge, the BOSScsc® was engineered with an ultra-low crossing profile coupled with the most advanced and proven hydrophilic coating on the market.
The BOSScsc® Crossing Support Catheter platform is FDA 510(k) cleared to be used in the U.S.A. to guide and support a guidewire during access of the peripheral vasculature, allow for wire exchanges, and provide a conduit for the delivery of saline solutions or diagnostic contrast agents.
Chief Executive Officer, Founder,
Chris was the founder of DirectACCESS Medical where he partnered with Davita and lead the development and commercialization of PTA balloon technology for dialysis access procedures. DirectACCESS Medical was acquired by Merit Medical in 2018. His early professional career was with Edwards Lifesciences where he held multiple positions in sales, marketing, management, and business development. While at Edwards he was responsible for the global commercialization of the Fogarty® catheter products invented by Dr. Thomas J. Fogarty.
Chief Technology Officer, Board Member
Chris has over 29 years experience in developing and commercializing catheter based medical device technology. His engineering experience spans vascular stents, embolics, vascular access devices, angioplasty catheters, angiography catheters, and guide catheters at Boston Scientific, AngioDynamics, and C.R. Bard. He holds an MBA from Northeastern University and relocated to Ireland in 2005 to co-found Marvao Medical Devices. Chris has a distinguished portfolio of innovation being listed as inventor on 14 patents and multiple recent patent applications.
Chief Commercial Officer,
John was the co-founder of DirectACCESS medical where he orchestrated the US distribution and commercialization strategy for the FirstChoice UHP PTA™ line of specialty angioplasty catheters. His efforts built a multi-million dollar enterprise with a hybrid sales channel that resulted in an acquisition by Merit Medical. John has spent over 30 years introducing new specialty technologies to a variety of medical device markets. He has lead commercialization efforts at Edwards Lifesciences, Imagyn Medical, and US Surgical.
Chief Medical Officer, Inventor,
Dr. Mustapha is a board-certified interventional cardiologist who specializes in endovascular revascularization of critical limb ischemia. He is the co-founder and Chief Executive Officer of ACV Centers in Grand Rapids, Michigan. He has multiple publications on CLI/CLTI and limb salvage, is the Founder and Director of the Amputation Prevention Symposium, and is a Founding Board Member of the CLI Global Society. Dr. Mustapha is a medical device innovator and inventor with multiple assigned patents.
Mark is a medical device entrepreneur and founder of Advanced Polymers, manufacturer of the industry’s thinnest, strongest and smallest heat-shrink tubing and specialized medical balloons. After merging with Vention Medical he served as President, Chief Technology Officer, and Board Member. In 2017 Vention was acquired by Nordson Medical. The UMass Lowell Emerging Technologies and Innovation Center has been named after Mark Saab and his wife Elisia.
Copyright © 2023 Iatri Devices - All Rights Reserved.
Powered by People